publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
background
aminopeptidas
activ
bradykinin
degrad
mani
inflammatori
peptid
object
object
studi
identifi
type
aminopeptidas
activ
human
nasal
mucosa
method
human
nasal
mucosa
homogen
n
cytoplasm
membranerich
fraction
obtain
sever
aminopeptidas
ap
activ
defin
substrat
specif
leucineenkephalin
leuap
alaninenitroanilid
alaap
inhibitor
studi
puromycin
bestatin
enzym
activ
histochemistri
zymographi
immunohistochemistri
gel
electrophoresi
human
volunt
methacholin
histamin
allergen
nasal
provoc
determin
mechan
control
nasal
aminopeptidas
secret
vivo
igg
detect
immunoreact
materi
epithelium
gland
endothelium
nasal
provoc
studi
leuap
correl
glandular
exocytosi
vascular
leak
conclus
predomin
aminopeptidas
human
nasal
epitheli
submucos
gland
cell
membranebound
puromycinresist
aminopeptidas
novel
solubl
puromycinresist
aminopeptidas
lower
amount
solubl
psap
also
detect
j
allergi
clin
immunol
wide
rang
peptidolyt
activ
describ
includ
aminopeptidas
digest
peptid
nterminu
carboxypeptidas
neutral
endopeptidas
nep
angiotensinconvert
enzym
ace
cleav
intern
peptid
bond
airway
mucosa
aminopeptidas
may
critic
gener
bradykinin
may
also
reduc
durat
action
bradykinin
neuropeptid
releas
nocicept
neuron
eg
substanc
p
proinflammatori
peptid
aminopeptidas
activ
frequent
identifi
use
leucineenkephalin
enkephalindegrad
aminopeptidas
leuap
substrat
major
enkephalindegrad
aminopeptidas
activ
initi
describ
basi
arylamidas
activ
subsequ
refer
either
aminopeptidas
apm
also
known
aminopeptidas
n
puromycinsensit
aminopeptidas
psap
apm
integr
membran
protein
rel
resist
inhibit
puromycin
coeffici
inhibit
ki
mmoll
psap
predominantli
cytosol
enzym
found
associ
membran
sensit
inhibit
puromycin
ki
approxim
apm
psap
inhibit
bestatin
cdna
rat
kidney
apm
human
psap
clone
respect
amino
acid
sequenc
deduc
begin
defin
physiolog
aminopeptidas
airway
use
multipl
assay
character
aminopeptidas
activ
solubl
membran
fraction
human
nasal
mucosa
substrat
specif
assess
use
leucineenkephalin
leuap
activ
alaninenitroanilid
alaap
activ
inhibit
leuap
puromycin
defin
psap
rel
resist
activ
similar
studi
perform
bestatin
alaap
activ
local
cryostat
tissu
section
enzym
activ
histochemistri
zymographi
wherea
psapimmunoreact
materi
identifi
immunohistochemistri
studi
complement
previou
analys
neutral
endopeptidas
neprilysin
nep
calla
ace
carboxypeptidas
n
cpn
also
modul
neurogen
peptidemedi
inflammatori
event
human
inferior
nasal
turbin
obtain
time
surgeri
patient
nasal
airway
obstruct
previous
describ
tissu
dissect
conchal
bone
within
minut
excis
immedi
prepar
futur
use
six
mucos
specimen
use
enzym
assay
frozen
dri
ice
second
store
frozen
turbin
weigh
averag
wet
weight
mg
rang
mg
fine
dissect
razor
blade
suspend
volum
volumewet
tissu
weight
moll
sucros
mmoll
tri
hcl
ph
homogen
polytron
homogen
std
tissum
tekmar
cincinnati
ohio
maximum
speed
second
twice
homogen
centrifug
minut
supernat
collect
pellet
suspend
buffer
recentrifug
rate
pellet
discard
supernat
combin
design
centrifug
minut
result
supernat
collect
pellet
membran
fraction
wash
resuspend
mmoll
tri
hcl
ph
design
nasal
extract
sampl
incub
mmoll
tri
hcl
buffer
ph
h
leuenkephalin
cimmol
nendupont
wilmington
del
nmoll
final
concentr
tracer
leucineenkephalin
final
concentr
peninsula
laboratori
belmont
calif
substrat
phosphoramidon
final
concentr
peninsula
captopril
final
concentr
provid
gift
squibb
princeton
nj
ad
inhibit
nep
ace
activ
respect
incub
stop
minut
addit
hcl
metabolit
h
tyrosin
separ
nonmetabol
enkephalin
chromatographi
porapack
q
mesh
polystyren
bead
column
water
milford
mass
blank
obtain
parallel
incub
perform
presenc
mmoll
puromycin
calbiochem
la
jolla
calif
bestatin
calbiochem
porcin
aminopeptidas
sigma
chemic
co
st
loui
mo
use
standard
confirm
assay
condit
inhibitor
activ
enkephalindegrad
aminopeptidas
activ
express
picomol
leuenkephalin
metabol
per
minut
per
milligram
protein
extract
picomol
leuenkephalin
metabol
per
minut
per
millilit
nasal
lavag
fluid
sampl
puromycin
bestatin
ad
leuap
concentr
moll
ki
defin
concentr
reduc
leuap
activ
alanin
aminopeptidas
alaap
assay
sampl
ad
cuvett
contain
ml
mmoll
tri
hcl
buffer
ph
phosphoramidon
captopril
mix
thoroughli
incub
minut
alana
sigma
concentr
mmoll
ad
kinet
nitroanilid
format
measur
absorb
nm
time
minut
catalyt
concentr
sampl
b
unit
per
millilit
calcul
b
puromycin
mmoll
ad
neg
control
sampl
rel
activ
toward
leuenkephalin
alana
compar
sampl
use
competit
assay
km
determin
substrat
first
set
competit
studi
leuenkephalin
ad
km
concentr
along
wide
rang
alana
concentr
determin
effect
leuenkephalin
alana
assay
similarli
alana
ad
km
leuenkephalin
assay
determin
degre
interact
rat
brainsolubl
psap
purifi
describ
femal
goat
inject
subcutan
enzym
boost
protein
incomplet
freund
adjuv
week
later
phlebotomi
igg
fraction
obtain
precipit
ammonium
sulfat
dialyz
pb
nasal
extract
treat
nativ
sampl
buffer
without
sd
mercaptoethanol
sampl
buffer
neg
control
appli
trisglycin
polyacrylamid
gel
novex
experiment
technolog
san
diego
calif
electrophores
stain
protein
coomassi
blue
pharmacia
lkb
piscataway
nj
enzym
activ
detect
place
gel
mmoll
lala
electrophoresi
protein
transfer
nativ
gel
nitrocellulos
membran
unilater
electrodiffus
blot
v
minut
membran
block
nonimmun
rabbit
serum
bsa
tri
buffer
nacl
mmoll
tri
hcl
ph
room
temperatur
minut
rins
twice
tri
buffer
incub
hour
psap
polyclon
antibodi
dilut
bsa
tri
buffer
wash
tri
buffer
membran
incub
phosphataselabel
rabbit
antigoat
igg
kirkegaard
perri
laboratori
gaithersburg
md
dilut
bsa
tri
buffer
room
temperatur
minut
wash
time
tri
buffer
membran
place
bcipnbt
phosphatas
substrat
kirkegaard
perri
minut
room
temperatur
color
reaction
termin
wash
larg
volum
distil
water
western
blot
sampl
concentr
centricon
microconcentr
amicon
danver
mass
prepar
concentr
approxim
mgml
approxim
mgml
nasal
lavag
approxim
mgml
fresh
tissu
n
fix
paraformaldehyd
pb
ph
hour
store
pb
embed
paraffin
sixmicronthick
paraffin
section
clear
xylen
grade
alcohol
wash
water
pb
block
bsa
pb
section
incub
goat
polyclon
antirat
brainsolubl
psap
dilut
bsa
pb
hour
humidifi
chamber
wash
pb
incub
colloid
goldlabel
rabbit
antigoat
igg
biocel
ted
pella
red
calif
dilut
bsa
pb
room
temperatur
minut
wash
time
pb
minut
time
distil
water
minut
room
temperatur
silver
enhanc
solut
intens
janssen
ad
develop
stain
slide
monitor
light
microscopi
slide
wash
distil
water
counterstain
nuclear
fast
red
cryostat
section
cut
frozen
tissu
n
allow
dri
room
temperatur
fixat
analyt
grade
aceton
minut
follow
brief
dri
air
aminopeptidas
activ
demonstr
use
simultan
azocoupl
techniqu
lalamna
final
con
centrat
mmoll
fast
blue
bb
salt
sigma
chemic
co
final
concentr
mgml
dimethylformamid
trismal
buffer
ph
slide
incub
substrat
minut
wash
minut
distil
water
fix
minut
aqueou
formalin
rins
briefli
distil
water
mount
glycerol
gelatin
site
lalamna
catabol
identifi
red
stain
tissu
total
adult
subject
male
femal
age
year
studi
subject
exclud
upper
respiratori
tract
infect
past
week
nasal
symptom
time
studi
take
medic
previou
hour
atop
subject
n
perenni
n
season
n
symptom
defin
least
posit
allergi
prick
skin
test
wheal
mm
glycerol
neg
control
panel
relev
aeroallergen
season
atop
subject
studi
allergi
season
nonatop
subject
n
allerg
symptom
neg
skin
test
result
nasal
challeng
perform
previous
report
nasal
lavag
fluid
collect
rubber
cathet
nasal
caviti
wash
salin
prewash
challeng
protocol
begun
nasal
challeng
solut
prepar
normal
salin
appli
one
side
nasal
caviti
nebul
bottl
challeng
period
follow
salin
lavag
first
protocol
subject
challeng
sequenti
salin
follow
mg
methacholin
second
protocol
salin
challeng
follow
challeng
mg
histamin
third
protocol
subject
sequenti
challeng
atropin
mg
methacholin
final
patient
receiv
allergen
challeng
previous
describ
baselin
secret
collect
minut
salin
challeng
solut
relev
allergen
pnu
instil
lavag
collect
everi
minut
first
hour
everi
minut
second
hour
leuap
assess
describ
except
nasal
lavag
sampl
incub
h
leuenkephalin
nmoll
final
concentr
leuenkephalin
final
concentr
mmoll
tri
hcl
ph
lactoferrin
measur
modifi
noncompetit
elisa
assay
rang
ngml
albumin
measur
direct
competit
elisa
assay
rang
igg
measur
direct
noncompetit
elisa
assay
rang
ngml
total
protein
measur
lowri
method
bsa
standard
leuap
activ
detect
cytosol
fraction
membranerich
fraction
adult
human
nasal
turbin
specif
activ
significantli
higher
fraction
pmolminmg
protein
rang
fraction
pmolminmg
protein
rang
p
sampl
ki
valu
puromycin
higher
bestatin
fig
puromycin
complet
inhibit
leuap
activ
sampl
high
concentr
fraction
compon
discern
puromycinsensit
fraction
repres
total
edap
activ
exhibit
ki
behavior
consist
fraction
solubl
psap
remain
activ
ki
thu
repres
novel
aminopeptidas
activ
activ
fraction
exhibit
high
ki
puromycin
thu
psap
detect
membran
fraction
bestatin
inhibit
leuap
activ
ki
ki
alaap
activ
detect
fraction
activ
fraction
mumg
protein
rang
fraction
higher
activ
mumg
protein
rang
km
leuenkephalin
mmoll
mmoll
fig
alana
substrat
km
mmoll
mmoll
addit
mmoll
alana
sampl
shift
leuenkephalin
degrad
curv
right
fraction
addit
mmoll
alana
increas
km
addit
mmoll
leuenkephalin
fraction
shift
km
alana
mmoll
increas
similarli
km
alana
increas
leuenkephalin
fraction
data
indic
leuenkephalin
alana
measur
aminopeptidas
activ
electrophoresi
dilut
concentr
mgml
mgml
fraction
follow
lalanma
azocoupl
zymographi
demonstr
singl
band
prepar
mobil
fig
differ
concentr
suggest
higher
specif
activ
aminopeptidas
membranerich
fraction
psap
may
low
activ
detect
method
solubl
psapimmunoreact
materi
local
epithelium
submucos
gland
endothelium
human
nasal
turbin
mucosa
fig
intens
stain
concentr
outer
layer
epithelium
specimen
immunoreact
identifi
columnar
basal
cell
goblet
cell
vacuol
fig
submucos
gland
immunoreact
seen
serou
mucou
cell
fig
c
serou
cell
immunoreact
intens
fig
glandular
stain
inconsist
sampl
suggest
variabl
express
loss
exocytosi
process
immunoreact
seen
small
fig
larg
vein
endotheli
cell
fig
enzym
histochemistri
use
local
lalamnacleav
aminopeptidas
epithelium
submucos
gland
fig
c
lalamna
histozymogram
inhibit
preincub
puromycin
minut
fig
b
glandular
stain
concentr
lumen
surfac
acinar
cell
make
difficult
distinguish
serou
cell
mucou
cell
almost
lalamna
activ
either
small
larg
vessel
leuap
activ
salin
challeng
pmolminml
rang
methacholin
provoc
increas
leuap
activ
pmolminml
rang
indic
activ
secret
pretreat
atropin
block
methacholineinduc
leuap
releas
pmolminml
rang
histamin
increas
leuap
pmolminml
rang
methacholin
stimul
glandular
exocytosi
secret
wherea
histamin
caus
vascular
leak
extravas
plasma
protein
plu
stimul
nocicept
nerv
recruit
cholinerg
reflex
caus
glandular
exocytosi
secretori
data
suggest
cholinerg
stimul
gland
direct
reflex
action
predomin
mechan
regul
leuap
secret
human
nasal
mucosa
vivo
determin
leuap
secret
occur
associ
glandular
andor
vascular
protein
leuap
activ
secret
compar
total
protein
lactoferrin
specif
marker
serou
cell
secret
albumin
plasma
protein
marker
reflect
vascular
permeabl
fig
methacholin
provoc
fig
b
c
leuap
highli
correl
lactoferrin
r
p
total
protein
r
p
wherea
leuap
albumin
secret
correl
r
signific
histamin
provoc
fig
e
f
leuap
correl
total
protein
r
p
lactoferrin
r
p
albumin
r
p
data
agreement
studi
histamin
provoc
show
parallel
stimul
vascular
permeabl
cholinerg
reflexmedi
glandular
secret
thu
methacholin
histamin
provoc
system
indic
leuap
secret
correl
close
glandular
secret
repeat
salin
challeng
minut
fig
effect
leuap
content
nasal
lavag
fluid
allergen
given
minut
induc
sneez
rhinorrhea
nasal
pruritu
congest
subject
within
minut
challeng
nasal
lavag
enrich
total
protein
albumin
igg
lactoferrin
leuap
increas
minut
challeng
minut
reach
maximum
concentr
minut
time
point
return
baselin
minut
allergen
leuap
level
first
hour
allergen
minut
significantli
higher
level
salin
minut
second
minut
lavag
fluid
p
analysi
varianc
multipl
comparison
bonferroni
correct
signific
differ
individu
time
point
wide
varianc
leuap
valu
leuap
releas
minut
correl
lactoferrin
r
p
igg
r
p
total
protein
r
p
fig
experi
indic
leuap
secret
increas
immedi
phase
allerg
reaction
identif
ap
activ
human
nasal
mucosa
difficult
divers
assay
substrat
inhibitor
requir
despit
limit
aminopeptidas
activ
discov
major
aminopeptidas
activ
approxim
found
membranerich
tissu
fraction
puromycinresistantbestatinsensit
aminopeptidas
probabl
repres
epitheli
glandular
cell
surfac
apm
activ
solubl
fraction
contain
remain
approxim
total
aminopeptidas
activ
solubl
aminopeptidas
activ
also
detect
urin
bile
acid
serum
nasal
lavag
fluid
approxim
activ
total
extract
aminopeptidas
activ
attribut
psap
psapimmunoreact
materi
local
epithelium
gland
endothelium
use
antirat
brainsolubl
psap
releas
solubl
enzym
exocrin
cell
may
cholinerg
control
bulk
activ
total
aminopeptidas
activ
solubl
puromycininsensitivebestatin
sensit
aminopeptidas
activ
may
correspond
novel
aminopeptidas
recent
describ
erbeznik
hersh
ki
puromycin
mmoll
mmoll
bestatin
macromolecul
may
dimer
high
salt
led
dissoci
one
electrophoret
band
may
correspond
alaap
activ
detect
epithelium
gland
cell
zymographi
fig
b
nasal
provoc
experi
demonstr
methacholin
antigen
histamin
could
induc
aminopeptidas
secret
correl
exocytosi
marker
glandular
secret
marker
vascular
permeabl
glandular
exocytosi
regul
cholinerg
reflex
parasympathet
pathway
may
regul
aminopeptidas
activ
secret
mucu
benefit
secret
aminopeptidas
airway
mucu
may
includ
antivir
activ
capac
gener
bradykinin
cell
surfac
aminopeptidas
act
bind
site
coronavirus
conceiv
mucu
aminopeptidas
may
bind
virion
prevent
epitheli
cell
bind
uptak
infect
virion
destruct
could
mediat
plasma
protein
aminopeptidas
gener
bradykinin
one
precursor
lysylbradykinin
kallidin
bradykinin
potent
stimul
vascular
permeabl
caus
flood
airway
lumen
immunoglobulincontain
complementcontain
fibrincontain
plasma
vasodil
nocicept
sensori
nerv
activ
convey
sensat
burn
pain
arachidon
acid
metabol
promot
addit
glandular
exocytosi
also
occur
bradykinin
elev
secret
common
cold
allergen
provoc
howev
bradykinin
antagonist
littl
effect
common
cold
inhibit
aminopeptidas
bestatin
accentu
vascular
permeabl
induc
tobacco
hamster
cheek
pouch
model
find
suggest
altern
hypothesi
secret
glandular
aminopeptidas
along
kininogen
vascular
glandular
origin
airway
mucu
lead
bradykinin
product
consequ
marker
parallel
secret
rather
primari
caus
mucos
inflamm
compet
hypothes
requir
addit
test
includ
human
nasal
provoc
aminopeptidas
inhibitor
bestatin
